Market Cap : 230.58 B | Enterprise Value : 252.11 B | PE Ratio : 13.94 | PB Ratio : 5.33 |
---|
NYSE:MRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Good Sign:
Altman Z-score of 4.17 is strong.
Merck has a Altman Z-Score of 4.17, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Merck's Altman Z-Score or its related term are showing as below:
During the past 13 years, Merck's highest Altman Z-Score was 12.06. The lowest was 2.40. And the median was 4.48.
The historical data trend for Merck's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Merck's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Merck's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Merck's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Merck's Altman Z-Score for today is calculated with this formula:
Z | = | 1.2 | * | X1 | + | 1.4 | * | X2 | + | 3.3 | * | X3 | + | 0.6 | * | X4 | + | 1.0 | * | X5 |
= | 1.2 | * | 0.0836 | + | 1.4 | * | 0.5457 | + | 3.3 | * | 0.1813 | + | 0.6 | * | 3.6154 | + | 1.0 | * | 0.5338 | |
= | 4.17 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Trailing Twelve Months (TTM) ended in Jun. 2022:
Total Assets was $107,095 Mil.
Total Current Assets was $32,116 Mil.
Total Current Liabilities was $23,168 Mil.
Retained Earnings was $58,437 Mil.
Pre-Tax Income was 4487 + 4861 + 3909 + 5266 = $18,523 Mil.
Interest Expense was -240 + -243 + -209 + -196 = $-888 Mil.
Revenue was 14593 + 15901 + 13521 + 13154 = $57,169 Mil.
Market Cap (Today) was $230,579 Mil.
Total Liabilities was $63,777 Mil.
* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.
X1 | = | Working Capital | / | Total Assets |
= | (Total Current Assets - Total Current Liabilities) | / | Total Assets | |
= | (32116 - 23168) | / | 107095 | |
= | 0.0836 |
X2 | = | Retained Earnings | / | Total Assets |
= | 58437 | / | 107095 | |
= | 0.5457 |
X3 | = | Earnings Before Interest and Taxes | / | Total Assets |
= | (Pre-Tax Income - Interest Expense) | / | Total Assets | |
= | (18523 - -888) | / | 107095 | |
= | 0.1813 |
X4 | = | Market Value Equity | / | Book Value of Total Liabilities |
= | Market Cap | / | Total Liabilities | |
= | 230579.131 | / | 63777 | |
= | 3.6154 |
X5 | = | Revenue | / | Total Assets |
= | 57169 | / | 107095 | |
= | 0.5338 |
The zones of discrimination were as such:
Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones
Merck has a Altman Z-Score of 4.17 indicating it is in Safe Zones.
Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Read more about Altman Z-Score and the original research.
Altman Z-Score does not apply to financial companies.
Thank you for viewing the detailed overview of Merck's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Baker Douglas M Jr | director | 370 WBASHA ST NORTH ST PAUL MN 55102 |
Oosthuizen Johannes Jacobus | officer: SVP, U.S. Market | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Garay Arpa | officer: SVP Human Health Global Mktg. | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Downing Cristal N | officer: Chief Comm. & Public Afrs Ofcr | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Klobuchar Michael A | officer: EVP - Chief Strategy Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Lecointe-cephas Lisa | officer: SVP Chief Ethics & Com Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Litchfield Caroline | officer: EVP & CFO | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Mayo Stephen | director | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Li Dean Y | officer: Executive VP & President, MRL | 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Williams David Michael | officer: EVP,Chief Info&Digital Officer | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Lavizzo-mourey Risa J | director | GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210 |
Seidman Christine E | director | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Warden Kathy J | director | 2980 FAIRVIEW PARK DRIVE FALLS CHURCH VA 22042 |
Craig Pamela | director | C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601 |
Brun Leslie A | director | 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 |
From GuruFocus
By Business Wire 03-01-2022
Other Sources
By Zacks 2022-03-22
By Zacks 2022-04-04
By Zacks 2022-03-23
By Zacks 2022-03-29
By Zacks 2022-03-28
By tipranks.com 2022-03-28
By Zacks 2022-04-04
By Zacks 2022-03-31
By Zacks 2022-03-25
By Zacks 2022-03-25
By Zacks 2022-03-29
By Zacks 2022-04-05